Recombinant oncolytic herpes simplex virus type 1 (R130) Clinical Trials
2 recruitingDrug
Early Phase 12
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Breast CancerSarcomaLung Cancer+7 more
Shanghai Yunying Medical Technology20 enrolled1 locationNCT05961111
Recruiting
Early Phase 1
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
Esophageal CancerHead and Neck CancerLaryngeal Cancer+4 more
Shanghai Yunying Medical Technology9 enrolled1 locationNCT05830240